Cargando…

Estimation of Cardiorespiratory fitness using a using a chest mounted accelerometer

 : Cardiorespiratory fitness expressed as maximal oxygen consumption (V̇O(2 max)) is a strong predictor of cardiovascular health. However, quantification of cardiorespiratory fitness by cardiopulmonary exercise (CPX) assessment is complex and costly and therefore not suitable in most clinical settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, S E, Hansen, M T, Roemer, T, Soegaard, P, Helge, J W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779770/
http://dx.doi.org/10.1093/ehjdh/ztac076.2769
Descripción
Sumario: : Cardiorespiratory fitness expressed as maximal oxygen consumption (V̇O(2 max)) is a strong predictor of cardiovascular health. However, quantification of cardiorespiratory fitness by cardiopulmonary exercise (CPX) assessment is complex and costly and therefore not suitable in most clinical settings. In the current study we develop and validate an algorithm for estimation of V̇O(2 max) using seismocardiography (SCG-V̇O(2 max)). SCG is measurement of precordial vibrations using an accelerometer. METHODS: SCG recordings and results from ergometer CPX testing of V̇O(2 max) in 300 subjects from six clinical studies were combined in a database. 83 subjects underwent repeated measurements sessions across several days. SCG was obtained using a sensitive accelerometer, located on the lower sternum at the Xiphoid protrusion and subjects were placed in a supine position. 5 subjects were excluded due to cardiovascular disease, or missing data. A machine learning algorithm was devolved for estimation of V̇O(2 max) in a training set including 221 subjects. The remaining 74 subjects were included in a test set for validation. Correlation and accuracy between SCG-V̇O(2 max) and ergometer CPX V̇O(2 max) assessed and day to day variation was assessed in subjects who underwent multiple ergometer CPX sessions. RESULTS: In 144 recordings from 74 test set subjects SCG-V̇O(2 max) was 45.0±9.3 ml/min/kg which was comparable to the ergometer CPX V̇O(2 max) at 44.3±10.1 ml/min/kg (p=0.09) and correlation between ergometer CPX V̇O(2 max) and SCG-V̇O(2 max) was r=0.875. Mean average percentage error was 8.7%. Day to day variation measured as the within-subjects-standard-deviation was 1.2 ml/min/kg for SCG-V̇O(2 max) and 1.7 ml/min/kg for ergometer CPX. CONCLUSIONS: SCG based estimation of VV̇O(2 max) is a novel, low cost, easy to use and accurate estimation method of CRF with a high level of reproducibility. SCG-V̇O(2 max) can potentially facilitate that cardiorespiratory fitness becomes an integrated part of modern health assessment. FUNDING ACKNOWLEDGEMENT: Type of funding sources: Private company. Main funding source(s): VentriJect A/S DK